Schwab Charles Investment Management Inc. raised its holdings in shares of Imperva Inc (NASDAQ:IMPV) by 12.6% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 156,057 shares of the software maker’s stock after buying an additional 17,453 shares during the period. Schwab Charles Investment Management Inc.’s holdings in Imperva were worth $6,196,000 as of its most recent SEC filing.
A number of other large investors have also modified their holdings of the stock. Wells Fargo & Company MN lifted its position in shares of Imperva by 11.9% in the 3rd quarter. Wells Fargo & Company MN now owns 213,953 shares of the software maker’s stock valued at $9,285,000 after acquiring an additional 22,741 shares in the last quarter. Prudential Financial Inc. lifted its position in shares of Imperva by 80.7% in the 3rd quarter. Prudential Financial Inc. now owns 54,174 shares of the software maker’s stock valued at $2,351,000 after acquiring an additional 24,190 shares in the last quarter. American Century Companies Inc. purchased a new stake in shares of Imperva in the 3rd quarter valued at approximately $6,832,000. Bank of New York Mellon Corp lifted its position in shares of Imperva by 10.8% in the 3rd quarter. Bank of New York Mellon Corp now owns 150,752 shares of the software maker’s stock valued at $6,542,000 after acquiring an additional 14,727 shares in the last quarter. Finally, Allianz Asset Management GmbH lifted its position in shares of Imperva by 58.1% in the 3rd quarter. Allianz Asset Management GmbH now owns 59,149 shares of the software maker’s stock valued at $2,567,000 after acquiring an additional 21,732 shares in the last quarter.
Several equities research analysts recently commented on IMPV shares. Morgan Stanley upped their price target on shares of Imperva from $37.00 to $39.00 and gave the company an “underweight” rating in a research report on Friday, February 9th. ValuEngine upgraded shares of Imperva from a “sell” rating to a “hold” rating in a research report on Thursday, February 15th. BidaskClub upgraded shares of Imperva from a “hold” rating to a “buy” rating in a research report on Wednesday, February 7th. Evercore ISI set a $56.00 price target on shares of Imperva and gave the company a “buy” rating in a research report on Friday, February 9th. Finally, Imperial Capital upped their price target on shares of Imperva from $50.00 to $55.00 and gave the company an “outperform” rating in a research report on Friday, February 9th. Three analysts have rated the stock with a sell rating, four have assigned a hold rating, eleven have assigned a buy rating and one has given a strong buy rating to the company. Imperva currently has an average rating of “Buy” and an average target price of $53.14.
Imperva (NASDAQ:IMPV) last released its earnings results on Thursday, February 8th. The software maker reported $0.40 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.27 by $0.13. Imperva had a net margin of 7.11% and a negative return on equity of 3.28%. The company had revenue of $91.10 million during the quarter, compared to the consensus estimate of $91.11 million. During the same quarter in the prior year, the firm earned $0.32 EPS. The company’s revenue was up 16.2% compared to the same quarter last year. sell-side analysts expect that Imperva Inc will post -0.17 earnings per share for the current year.
In other news, Director Anthony J. Bettencourt sold 66,037 shares of the firm’s stock in a transaction on Tuesday, February 20th. The shares were sold at an average price of $46.98, for a total transaction of $3,102,418.26. Following the transaction, the director now owns 66,037 shares in the company, valued at approximately $3,102,418.26. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CRO Michael D. Mooney sold 24,454 shares of the firm’s stock in a transaction on Tuesday, February 20th. The shares were sold at an average price of $47.18, for a total transaction of $1,153,739.72. Following the transaction, the executive now owns 24,454 shares in the company, valued at approximately $1,153,739.72. The disclosure for this sale can be found here. 1.90% of the stock is owned by corporate insiders.
WARNING: This piece was originally reported by Markets Daily and is owned by of Markets Daily. If you are reading this piece on another domain, it was illegally copied and reposted in violation of U.S. and international copyright & trademark law. The correct version of this piece can be viewed at https://www.themarketsdaily.com/2018/03/13/schwab-charles-investment-management-inc-raises-position-in-imperva-inc-impv.html.
Imperva Company Profile
Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.
Want to see what other hedge funds are holding IMPV? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Imperva Inc (NASDAQ:IMPV).
Receive News & Ratings for Imperva Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva and related companies with MarketBeat.com's FREE daily email newsletter.